Soligenix (SNGX) Director Jerome Zeldis Receives Option Award

What Happened Jerome B. Zeldis, a director of Soligenix, Inc. (SNGX), received an award of 78,947 derivative shares (stock option grant) on September 17, 2026. The grant is reported with an acquisition price of $0.00 in the Form 4; this reflects an awarded option/derivative rather than a cash purchase or sale. Because this is a grant (not a sale or immediate exercise), there was no cash exchanged at the time of the filing.

Key Details

• Transaction type: Grant / Award of derivative securities (code A)
• Transaction date: 2026-09-17; Form filed: 2026-09-18 (appears timely)
• Quantity: 78,947 derivative shares granted; reported acquisition price $0.00
• Shares owned after transaction: Not reported in the filing
• Footnote: Options vest ratably on Dec 17, 2026; Mar 17, 2027; Jun 17, 2027; Sep 17, 2027
• Filing timeliness: Reported the day after the grant; no late filing indicated

Context This filing documents an option/award grant, not an exercise or sale. The grant’s reported $0.00 acquisition value is typical for awards and does not indicate the eventual cash value to the insider—the actual value will depend on the option’s strike price (not specified here) and future stock performance, plus vesting. Such awards are commonly used for retention and compensation and do not, by themselves, indicate immediate buying or selling activity.